Literature DB >> 26077147

Mechanisms of activation of nucleus accumbens neurons by cocaine via sigma-1 receptor-inositol 1,4,5-trisphosphate-transient receptor potential canonical channel pathways.

Jeffrey L Barr1, Elena Deliu2, G Cristina Brailoiu3, Pingwei Zhao2, Guang Yan3, Mary E Abood4, Ellen M Unterwald5, Eugen Brailoiu6.   

Abstract

Cocaine promotes addictive behavior primarily by blocking the dopamine transporter, thus increasing dopamine transmission in the nucleus accumbens (nAcc); however, additional mechanisms are continually emerging. Sigma-1 receptors (σ1Rs) are known targets for cocaine, yet the mechanisms underlying σ1R-mediated effects of cocaine are incompletely understood. The present study examined direct effects of cocaine on dissociated nAcc neurons expressing phosphatidylinositol-linked D1 receptors. Endoplasmic reticulum-located σ1Rs and inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) were targeted using intracellular microinjection. IP3 microinjection robustly elevated intracellular Ca(2+) concentration, [Ca(2+)]i. While cocaine alone was devoid of an effect, the IP3-induced response was σ1R-dependently enhanced by cocaine co-injection. Likewise, cocaine augmented the [Ca(2+)]i increase elicited by extracellularly applying an IP3-generating molecule (ATP), via σ1Rs. The cocaine-induced enhancement of the IP3/ATP-mediated Ca(2+) elevation occurred at pharmacologically relevant concentrations and was mediated by transient receptor potential canonical channels (TRPC). IP3 microinjection elicited a slight, transient depolarization, further converted to a greatly enhanced, prolonged response, by cocaine co-injection. The cocaine-triggered augmentation was σ1R-dependent, TRPC-mediated and contingent on [Ca(2+)]i elevation. ATP-induced depolarization was similarly enhanced by cocaine. Thus, we identify a novel mechanism by which cocaine promotes activation of D1-expressing nAcc neurons: enhancement of IP3R-mediated responses via σ1R activation at the endoplasmic reticulum, resulting in augmented Ca(2+) release and amplified depolarization due to subsequent stimulation of TRPC. In vivo, intra-accumbal blockade of σ1R or TRPC significantly diminished cocaine-induced hyperlocomotion and locomotor sensitization, endorsing a physio-pathological significance of the pathway identified in vitro.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium; Endoplasmic reticulum; Imaging; Nucleus accumbens; Sigma receptors; Transient receptor potential channels

Mesh:

Substances:

Year:  2015        PMID: 26077147      PMCID: PMC4501893          DOI: 10.1016/j.ceca.2015.05.001

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  56 in total

Review 1.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Cocaine binding at sigma receptors.

Authors:  J Sharkey; K A Glen; S Wolfe; M J Kuhar
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

Review 3.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Authors:  S M Anderson; R C Pierce
Journal:  Pharmacol Ther       Date:  2005-02-26       Impact factor: 12.310

4.  Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels.

Authors:  Martin Kolisek; Andreas Beck; Andrea Fleig; Reinhold Penner
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Receptor-activated Ca2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. Evidence for a non-capacitative Ca2+ entry.

Authors:  X Zhu; M Jiang; L Birnbaumer
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  A L Gundlach; B L Largent; S H Snyder
Journal:  J Neurosci       Date:  1986-06       Impact factor: 6.167

Review 7.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

8.  Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells.

Authors:  Zhiping Wu; Wayne D Bowen
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

9.  Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects.

Authors:  Estefanía Moreno; David Moreno-Delgado; Gemma Navarro; Hanne M Hoffmann; Silvia Fuentes; Santi Rosell-Vilar; Paola Gasperini; Mar Rodríguez-Ruiz; Mireia Medrano; Josefa Mallol; Antoni Cortés; Vicent Casadó; Carme Lluís; Sergi Ferré; Jordi Ortiz; Enric Canela; Peter J McCormick
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

10.  Cocaine self-administration in rats lacking a functional trpc4 gene.

Authors:  Kristin C Rasmus; Casey E O'Neill; Ryan K Bachtell; Donald C Cooper
Journal:  F1000Res       Date:  2013-04-17
View more
  14 in total

1.  Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Authors:  Yuko Yasui; Tsung-Ping Su
Journal:  J Drug Alcohol Res       Date:  2016-02-20

2.  HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens.

Authors:  G Cristina Brailoiu; Elena Deliu; Jeffrey L Barr; Linda M Console-Bram; Alexandra M Ciuciu; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Drug Alcohol Depend       Date:  2017-06-08       Impact factor: 4.492

3.  Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors.

Authors:  G Cristina Brailoiu; Elena Deliu; Linda M Console-Bram; Jonathan Soboloff; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Biochem J       Date:  2015-10-14       Impact factor: 3.857

4.  N-arachidonoyl glycine, another endogenous agonist of GPR55.

Authors:  Linda Console-Bram; Sandra M Ciuciu; Pingwei Zhao; Robert E Zipkin; Eugen Brailoiu; Mary E Abood
Journal:  Biochem Biophys Res Commun       Date:  2017-07-08       Impact factor: 3.575

5.  Acute cocaine administration alters permeability of blood-brain barrier in freely-moving rats- Evidence using miniaturized fluorescence microscopy.

Authors:  Jeffrey L Barr; G Cristina Brailoiu; Mary E Abood; Scott M Rawls; Ellen M Unterwald; Eugen Brailoiu
Journal:  Drug Alcohol Depend       Date:  2019-10-18       Impact factor: 4.492

6.  Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine.

Authors:  Taylor A Gentile; Steven J Simmons; Mia N Watson; Krista L Connelly; Eugen Brailoiu; Yanan Zhang; John W Muschamp
Journal:  Neuropsychopharmacology       Date:  2017-07-25       Impact factor: 7.853

7.  Cocaine restricts nucleus accumbens feedforward drive through a monoamine-independent mechanism.

Authors:  Kevin M Manz; Benjamin C Coleman; Alexis N Jameson; Dipanwita G Ghose; Sachin Patel; Brad A Grueter
Journal:  Neuropsychopharmacology       Date:  2021-09-20       Impact factor: 7.853

8.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

Review 9.  Emerging Benefits: Pathophysiological Functions and Target Drugs of the Sigma-1 Receptor in Neurodegenerative Diseases.

Authors:  Ning-Hua Wu; Yu Ye; Bin-Bin Wan; Yuan-Dong Yu; Chao Liu; Qing-Jie Chen
Journal:  Mol Neurobiol       Date:  2021-08-12       Impact factor: 5.590

10.  Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine.

Authors:  Jeffrey L Barr; Pingwei Zhao; G Cristina Brailoiu; Eugen Brailoiu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.